Commercializing in vitro molecular tests for cancer screening.
Industry: Health Care
Latest Trade: $0.24 0.00 (0.0%)
First Day Return: +99.8%
Return from IPO: -95.2%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 10/12/2021 |
Offer Price | $5.00 |
Price Range $4.00 - $6.00 | |
Offer Shares (mm) | 2.0 |
Deal Size ($mm) | $10 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 11/04/2021 |
Offer Price | $5.00 |
Price Range $4.00 - $6.00 | |
Offer Shares (mm) | 2.0 |
Deal Size ($mm) | $10 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
Underwriters |
---|
Boustead Securities |
Company Data | |
---|---|
Headquarters | Mainz, Germany |
Founded | 2008 |
Employees at IPO | 22 |
Website mainzbiomed.com |